A bridge to span the gaps between industry, academia and policy
Reading the runes for venture capital
Ireland’s largest-ever healthcare venture capital fund makes an optimistic debut as one of the UK’s longest-standing VC supporters of high tech start-ups calls it quits.
Biotech’s risk profile is shifting
Biotechnology and risk have always been synonymous. But now those risks are evolving and growing, exposing companies to fresh hazards.
Growth in industry partnerships for
diseases of the developing world
Numbers of public–private partnerships addressing unmet medical needs in the developing world are growing fast.
Nanomedicine: Going small for big results
By carefully manipulating materials at the nanoscale, researchers hope to devise more effective and personalised medical diagnostics and therapies.
Meeting the needs of all stakeholders in future healthcare – a real possibility?


Subscribers only






